Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05777278
Status:
RECRUITING
Last Update Posted:
2023-10-10
First Post:
2023-02-21
Brief Title:
Savolitinib Plus Docetaxel as 2L in EGFRALKROS1MET ex14m-wildtype NSCLC With MET Overexpression
Sponsor:
Organization:
The First Affiliated Hospital of Guangzhou Medical University